Street Calls of the Week
Decheng Capital, a significant shareholder in BeyondSpring Inc (NASDAQ:BYSI), has sold a portion of its holdings, according to a recent Form 4 filing. The sales, which occurred on October 16 and 17, 2025, involved a total of 131,311 ordinary shares, generating $227,675. The transaction comes as BeyondSpring’s stock has shown strong momentum, gaining over 32% in the past six months, according to InvestingPro data.
The shares were sold at prices ranging from $1.72 to $1.76. On October 16, 85,798 shares were sold at prices ranging from $1.62 to $1.795. The following day, October 17, an additional 45,513 shares were sold in the range of $1.73 to $1.80. With a current market capitalization of $71.39 million and a healthy current ratio of 2.19, BeyondSpring maintains strong liquidity. InvestingPro subscribers can access 8 additional key insights about BYSI’s financial health.
These transactions were executed by Decheng Capital China Life Sciences USD Fund III, L.P. Following these sales, Decheng Capital China Life Sciences USD Fund III, L.P. directly holds 1,518,893 shares.
Decheng Capital China Life Sciences USD Fund II, L.P. continues to hold 1,617,409 shares, and Decheng Capital Global Healthcare Fund (Master), LP holds 891,734 shares in BeyondSpring Inc .
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
